The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for ivacaftor (Vertex Pharmaceuticals Australia Pty Ltd)
Active ingredients
ivacaftor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Tablet and granules
Indication
For the treatment of cystic fibrosis
Therapeutic area
Respiratory